Breaking News Instant updates and real-time market news.

CVS

CVS Health

$79.02

(0.00%)

, AET

Aetna

$184.56

0.35 (0.19%)

14:44
01/12/18
01/12
14:44
01/12/18
14:44

CVS intends to keep Aetna's headquarters in Connecticut, Reuters reports

CVS Health (CVS) said in intends to maintain Aetna's (AET) headquarters in Connecticut after it completes its $69B takeover of the U.S. health insurer, Reuters reports. "We have no plans to relocate Aetna's operations from Hartford and, in fact, view Hartford as the future location of our center of excellence for the insurance business," a CVS spokesperson said in an email, according to Reuters. CVS will still be headquartered in Rhode Island, the report notes. Reference Link

CVS

CVS Health

$79.02

(0.00%)

AET

Aetna

$184.56

0.35 (0.19%)

CVS CVS Health
$79.02

(0.00%)

01/05/18
RHCO
01/05/18
NO CHANGE
Target $90
RHCO
Buy
CVS Health price target raised to $90 from $85 at SunTrust
SunTrust analyst David MacDonald raised his price target on CVS Health to $90 after the company's FY18 outlook highlighted "solid underlying trends". MacDonalds says the company's operating income growth is in line with his estimate despite the "more pronounced headwind from the Anthem (ANTM) implementation and RxCrossroads divestiture", while remaining bullish on the pending Aetna (AET) deal and the benefits from the recent corporate tax rate changes. The analyst keeps his Buy rating on CVS Health.
01/05/18
01/05/18
UPGRADE
Target $88

Overweight
CVS Health upgraded to Overweight on Aetna deal potential at Morgan Stanley
As previously reported, Morgan Stanley analyst Ricky Goldwasser upgraded CVS Health (CVS) to Overweight from Equal Weight, contending that its planned acquisition of Aetna (AET) creates a path for accelerating EBIT growth from synergies and new Aetna membership. He also believes that in 2021 and beyond CVS has an opportunity to reshape access to healthcare by leveraging existing real estate to create local healthcare hubs, he tells investors. Goldwasser raised his price target on CVS shares to $88 from $81, adding that management's track record gives him confidence and that tax reform gives the company an "underappreciated war chest."
01/05/18
01/05/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. CVS Health (CVS) upgraded to Overweight from Equal Weight at Morgan Stanley WITH analyst Ricky Goldwasser contending that its planned acquisition of Aetna (AET) creates a path for accelerating EBIT growth from synergies and new Aetna membership. 2. Eli Lilly (LLY) upgraded to Buy from Hold at Argus with analyst David Toung citing possible "blockbuster" launches of baricitinib and galcanezumab as well as a regulatory update on galcanezumab as potential 2018 catalysts. 3. Lowe's (LOW) was upgraded to Overweight from Equal Weight and Target (TGT) was upgraded to Equal Weight from Underweight at Barclays. 4. Foot Locker (FL) upgraded to Buy from Neutral at Buckingham with analyst Scott Krasik saying he believes key product assortments are improving and expects an inflection in comparables by the second quarter. 5. Jack in the Box (JACK) upgraded to Neutral from Sell at Goldman Sachs with analyst Karen Holthouse saying the company is a "strong beneficiary" of tax reform. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/12/18
COWN
01/12/18
NO CHANGE
Target $39
COWN
Outperform
Teladoc weakness a buying opportunity, says Cowen
Cowen analyst Charles Ryhee views the pullback in Teladoc (TDOC) shares as a buying opportunity as he views guidance as conservative. He sees room for upside in 2018 given conservative assumptions around key new starts, particularly FEP and Tricare. He said he sees continued growth in 2019 from CVS (CVS). Ryhee reiterated his Outperform rating and $39 price target on Teladoc shares.
AET Aetna
$184.56

0.35 (0.19%)

01/03/18
PIPR
01/03/18
UPGRADE
Target $207
PIPR
Overweight
Aetna upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst Sarah James upgraded Aetna (AET) to Overweight and raised her price target for the shares to $207 from $187. The analyst sees a potential "win-win" scenario surrounding the outcome of the CVS Health (CVS) buyout. If the deal goes through James sees 15% share upside. If the deal does not go through, Aetna is set up for "strong operational performance" with stock appreciation potential of 15% by year end, the analyst contends.
01/05/18
LEER
01/05/18
NO CHANGE
LEER
Leerink views Department of Labor guidance as positive for MCOs
The Department of Labor's guidance yesterday on expanding access to Association health plans could be negative for both acute and behavioral health facilities due to healthcare exchange dis-enrollment into less rich benefit plans, Leerink analyst Ana Gupte tells investors in a research note. The news, however, is positive for large commercial group employer focused managed care organizations such as UnitedHealth (UNH), Anthem (ANTM), Aetna (AET) and Cigna (CI), with limited to no downside for Centene (CNC) and Molina Healthcare (MOH), given their focus on low income exchange members, the analyst adds. She believes WellCare (WCG) will not be impacted. Gupte expects the level of coverage per insured life to deteriorate with the Department of Labor's order as "skinnier and short term health plans that partly circumvent the ten mandated Essential Health Benefits from the Affordable Care Act further reduce utilization."

TODAY'S FREE FLY STORIES

XLE

Energy Select Sector SPDR

$79.27

0.4 (0.51%)

11:46
05/22/18
05/22
11:46
05/22/18
11:46
Technical Analysis
Technical Take: Energy Select Sector SPDR hits new 52-week high »

At time of writing the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMRN

BioMarin

$85.71

-3.64 (-4.07%)

11:45
05/22/18
05/22
11:45
05/22/18
11:45
Recommendations
BioMarin analyst commentary  »

BioMarin 'raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 25

    May

  • 12

    Sep

DO

Diamond Offshore

$20.60

0.71 (3.57%)

11:45
05/22/18
05/22
11:45
05/22/18
11:45
Options
Diamond Offshore call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALB

Albemarle

$104.25

0.17 (0.16%)

11:41
05/22/18
05/22
11:41
05/22/18
11:41
Conference/Events
Albemarle management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 30

    May

  • 04

    Jun

  • 05

    Jun

GIS

General Mills

$42.00

0.23 (0.55%)

11:40
05/22/18
05/22
11:40
05/22/18
11:40
Conference/Events
General Mills management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

11:38
05/22/18
05/22
11:38
05/22/18
11:38
General news
4-Week Bill Auction Total Amount data reported »

4-Week Bill Auction Total…

11:38
05/22/18
05/22
11:38
05/22/18
11:38
General news
52-Week Bill Auction Bid/Cover data reported »

52-Week Bill Auction…

11:38
05/22/18
05/22
11:38
05/22/18
11:38
General news
52-Week Bill Auction Total Amount data reported »

52-Week Bill Auction…

MYND

MYnd Analytics

$2.66

-0.5 (-15.82%)

11:33
05/22/18
05/22
11:33
05/22/18
11:33
Syndicate
Breaking Syndicate news story on MYnd Analytics »

MYnd Analytics files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZO

AutoZone

$620.18

-45.5 (-6.84%)

11:32
05/22/18
05/22
11:32
05/22/18
11:32
Technical Analysis
Technical Take: AutoZone back near lows of the day »

After a brief bounce…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

TJX

TJX

$87.50

2.84 (3.35%)

11:30
05/22/18
05/22
11:30
05/22/18
11:30
Earnings
TJX sees Q2 revenue approx. $9B, consensus $8.47B »

Expects wage increases to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 24

    May

RCII

Rent-A-Center

$10.07

-0.14 (-1.37%)

11:30
05/22/18
05/22
11:30
05/22/18
11:30
Options
Notable ratio spread in Rent A Center »

Notable ratio spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TJX

TJX

$86.77

2.11 (2.49%)

11:28
05/22/18
05/22
11:28
05/22/18
11:28
Earnings
TJX sees FY19 revenue $37.7B-$37.9B, consensus $37.87B »

Expects pretax profit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 24

    May

TGT

Target

$76.39

-0.47 (-0.61%)

, AMZN

Amazon.com

$1,580.04

-5.51 (-0.35%)

11:27
05/22/18
05/22
11:27
05/22/18
11:27
Earnings
On The Fly: What to watch in Target's earnings report »

Target (TGT) is scheduled…

TGT

Target

$76.39

-0.47 (-0.61%)

AMZN

Amazon.com

$1,580.04

-5.51 (-0.35%)

WMT

Walmart

$84.33

-0.17 (-0.20%)

SHLD

Sears

$3.35

-0.29 (-7.97%)

JCP

J.C. Penney

$2.41

-0.1 (-3.99%)

KSS

Kohl's

$61.15

-4.32 (-6.60%)

W

Wayfair

$84.92

-0.6 (-0.70%)

TSLA

Tesla

$277.25

-7.24 (-2.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 22

    May

  • 23

    May

  • 30

    May

  • 01

    Jun

  • 04

    Jun

  • 19

    Jun

11:25
05/22/18
05/22
11:25
05/22/18
11:25
Conference/Events
RBC commodity strategist to hold a luncheon meeting »

Group Luncheon Meeting,…

ONCE

Spark Therapeutics

$74.00

0.97 (1.33%)

, BMRN

BioMarin

$85.77

-3.58 (-4.01%)

11:21
05/22/18
05/22
11:21
05/22/18
11:21
Recommendations
Spark Therapeutics, BioMarin analyst commentary  »

Spark Therapeutics should…

ONCE

Spark Therapeutics

$74.00

0.97 (1.33%)

BMRN

BioMarin

$85.77

-3.58 (-4.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 25

    May

  • 10

    Sep

  • 12

    Sep

ADSK

Autodesk

$138.56

1.05 (0.76%)

11:20
05/22/18
05/22
11:20
05/22/18
11:20
Options
Autodesk calls active ahead of earnings »

Autodesk calls active…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 14

    Jun

TJX

TJX

$86.18

1.52 (1.80%)

11:17
05/22/18
05/22
11:17
05/22/18
11:17
Hot Stocks
TJX 'disproportionally' attracting millennial customers »

TJX "very…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 24

    May

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
05/22/18
05/22
11:17
05/22/18
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
05/22/18
05/22
11:16
05/22/18
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
05/22/18
05/22
11:15
05/22/18
11:15
General news
Breaking General news story  »

4-Week Bill Auction to be…

TJX

TJX

$86.14

1.48 (1.75%)

11:13
05/22/18
05/22
11:13
05/22/18
11:13
Recommendations
TJX analyst commentary  »

JPMorgan stays Overweight…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 24

    May

CCJ

Cameco

$10.72

-0.66 (-5.80%)

11:10
05/22/18
05/22
11:10
05/22/18
11:10
Options
Call buyers in Cameco as shares see relative weakness »

Call buyers in Cameco as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SU

Suncor

$41.71

0.38 (0.92%)

11:08
05/22/18
05/22
11:08
05/22/18
11:08
Conference/Events
Suncor management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 25

    May

  • 11

    Jun

  • 12

    Jun

  • 13

    Jun

SAGE

Sage Therapeutics

$161.81

-1.43 (-0.88%)

11:04
05/22/18
05/22
11:04
05/22/18
11:04
Conference/Events
Sage Therapeutics management to meet with RBC Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 30

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.